ArticleCancer chemotherapy and pharmacology2012

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors.

Haruyasu Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.